Solventum Corp

NYSE:SOLVHealthcareSTOXX:EDD24BPrussell1000

$86.09+1.22%LiveIn session · ≈ AED 316.17 · Market cap $14.65B · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	59.3%	60.2%	57.7%	57.3%	55.6%	53.5%	—	—
Operating margin	19.6%	23.0%	20.8%	20.6%	12.6%	26.2%	26.2%	+0.0 pts
Net margin	15.6%	17.9%	16.5%	16.4%	5.8%	18.7%	18.7%	+0.0 pts
EBITDA margin	27.9%	30.3%	27.9%	27.2%	18.5%	30.6%	—	—
Return on equity	—	12.1%	11.4%	11.5%	16.2%	30.8%	30.8%	+0.0 pts
Return on assets	—	10.4%	9.9%	9.7%	3.3%	10.9%	10.9%	+0.0 pts
Return on capital employed	—	14.8%	13.8%	13.9%	8.8%	19.5%	—	—
Debt / equity	—	0.0×	0.0×	0.7×	2.7×	1.0×	1.0×	+0.0%
Debt / assets	—	0.8%	0.7%	59.5%	55.4%	35.2%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	2.8×	6.3×	—	—
Current ratio	—	1.6×	1.7×	1.5×	1.2×	1.2×	1.2×	+0.0%
Quick ratio	—	1.0×	1.0×	1.0×	0.8×	0.9×	—	—
Cash ratio	—	0.1×	0.0×	0.1×	0.3×	0.3×	0.3×	+0.0%
Asset turnover	—	0.6×	0.6×	0.6×	0.6×	0.6×	—	—
Inventory turnover	—	4.0×	3.9×	4.1×	3.8×	3.6×	—	—
Receivables turnover	—	6.9×	6.9×	6.2×	6.7×	8.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.